Published in Br J Haematol on April 01, 1977
Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre. Br Med J (Clin Res Ed) (1981) 1.74
ACP Broadsheet No. 145: July 1995. Investigation of patients with autoimmune haemolytic anaemia and provision of blood for transfusion. J Clin Pathol (1995) 1.39
Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. II. Specificity of erythrocyte-bound IgG. Clin Exp Immunol (1980) 1.15
Anti blood group-M autoantibodies with livedo reticularis, Raynaud's phenomenon, and anaemia. J Clin Pathol (1979) 0.75
Glucocorticoid-Responsive Cold Agglutinin Disease in a Patient with Rheumatoid Arthritis. Case Rep Rheumatol (2015) 0.75
Evaluation of methods for detecting alloantibodies underlying warm autoantibodies. Transfusion (1999) 2.66
Misinterpretation and misapplication of p values in antibody identification: the lack of value of a p value. Transfusion (1997) 2.36
Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med (1966) 2.33
First year donation patterns predict long-term commitment for first-time donors. Vox Sang (2005) 2.18
Anti-M causing delayed hemolytic transfusion reaction. Transfusion (1983) 2.04
More on p values in antibody identification. Transfusion (1998) 1.89
Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion (2000) 1.61
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Serum and cerebral spinal fluid complement and serum autoantibodies in systemic lupus erythematosus. Medicine (Baltimore) (1971) 1.52
Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology (2003) 1.51
Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion (1997) 1.51
A comprehensive transfusion medicine curriculum for medical students. Transfusion Medicine Academic Award Group. Transfusion (1995) 1.42
Factors affecting the labor efficiency of hospital-based blood bank laboratories. Transfusion (1994) 1.39
An unusual Donath-Landsteiner antibody detectable at 37 degrees C by the antiglobulin test. Transfusion (1985) 1.38
In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest (1969) 1.26
A new reagent (ZZAP) having multiple applications in immunohematology. Am J Clin Pathol (1982) 1.24
First-time blood donors: demographic trends. Transfusion (2001) 1.23
International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang (2011) 1.19
Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med (1982) 1.18
International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report. Vox Sang (2009) 1.17
Drug-induced immune hemolytic anemia. Am J Med (1975) 1.17
International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver Report. Vox Sang (2003) 1.16
Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood (1986) 1.14
Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA (1985) 1.13
Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang (2004) 1.11
Immunologic reactions of humans to cephalosporins. Postgrad Med J (1971) 1.11
Drug-induced immune haemolytic anaemia. Clin Haematol (1980) 1.11
Specificity and immunoglobulin characteristics of autoantibodies in acquired hemolytic anemia. J Immunol (1971) 1.10
Universal WBC reduction. Transfusion (2000) 1.06
Ferritin-antibody localization of erythrocyte antigenic sites in immunohemolytic anemias. J Immunol (1968) 1.06
Detecting alloantibodies in patients with autoantibodies. Transfusion (1999) 1.06
Immunologic cross-reactivity between penicillins and cephalosporins: a review. J Infect Dis (1978) 1.00
Variable mechanisms for low serum-complement in liver disease. Lancet (1971) 1.00
Autoantibodies in acquired hemolytic anemia with special reference to the LW system. Blood (1973) 1.00
Possible gonadal mosaicism in a family with hemoglobin Köln. Johns Hopkins Med J (1980) 0.98
Transfusing patients with autoimmune haemolytic anaemia. Lancet (1993) 0.96
Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy. Neurology (2009) 0.95
Clinical significance of anti-At(a). Vox Sang (1995) 0.95
Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation (1987) 0.93
Tn polyagglutination preceding acute leukemia. Blood (1979) 0.93
Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood (1991) 0.92
Increased IgG molecules bound to the surface of red blood cells of patients with sickle cell anemia. Blood (1984) 0.92
Quantitation of fetal-maternal hemorrhage by flow cytometry. A simple and accurate method. Am J Clin Pathol (1989) 0.90
International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report. Vox Sang (2007) 0.90
Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of eythroid progenitors. Transfus Med (2005) 0.89
The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera. Transfusion (1976) 0.89
The effects of storage and heparin on the activity of serum complement, with particular reference to the detection of blood group antibodies. Am J Clin Pathol (1970) 0.89
Erythrophagocytosis on the peripheral blood smear and paroxysmal cold hemoglobinuria. Transfusion (2001) 0.88
Immunohaematological cross-allergenicity between penicillin and cephalothin in humans. Clin Exp Immunol (1968) 0.88
Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion (1987) 0.88
Development of a single probe for documentation of chimerism following bone marrow transplantation. Am J Hum Genet (1987) 0.88
Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation (1988) 0.88
Detection of IgG sensitization of red cells with 125I staphylococcal protein A. Am J Hematol (1982) 0.87
Acquired loss of red cell Kell antigens. Br J Haematol (1987) 0.87
Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia. Transplantation (1982) 0.86
Correlations between quantitative assay of red cell-bound C3, serologic reactions, and hemolytic anemia. Blood (1974) 0.86
In vitro studies of the impact of transfusion on the detection of alloantibodies after autoadsorption. Transfusion (2000) 0.86
Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells. Transfus Med (2004) 0.86
Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration. J Immunol (1971) 0.86
Transfusing the patient with autoimmune hemolytic anemia. Clin Lab Med (1982) 0.86
Immunologic mechanisms in drug-induced cytopenias. Prog Hematol (1975) 0.85
A new elution procedure using chloroform, a nonflammable organic solvent. Vox Sang (1982) 0.85
Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method. Vox Sang (2002) 0.85
Application of flow cytometry to immunohematology. J Immunol Methods (1987) 0.85
International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012). Vox Sang (2013) 0.84
What do we mean by "Hyperhaemolysis" and what is the cause? Transfus Med (2012) 0.84
The in vivo metabolism of the third component of complement in systemic lupus erythematosus. Arthritis Rheum (1977) 0.84
Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion (1992) 0.84
Complement activation by Coccidioides immitis: in vitro and clinical studies. Infect Immun (1980) 0.84
Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity. Br J Haematol (1983) 0.83
Hemolysis associated with transplantation. Transfusion (1998) 0.83
The role of compatibility tests. (Report of a meeting sponsored by the Bureau of Biologics for the Blood Products Advisory Committee). Transfusion (1982) 0.83
A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med (1999) 0.83
An acute hemolytic transfusion reaction caused by an anti-P1 that reacted at 37 degrees C. Transfusion (1998) 0.83
An evaluation of commercial antiglobulin sera with particular reference to their anticomplement properties. Transfusion (1971) 0.82
Effect of storage on antibody reactivity after adsorption in the presence of polyethylene glycol. Transfusion (2000) 0.82
Autoimmune hemolytic anemia after Kawasaki disease in a child. Int J Hematol (1993) 0.82
Complement in immunohematology. Prog Clin Immunol (1974) 0.82
Evaluation of reticuloendothelial function in autoimmune hemolytic anemia using an in vitro assay of monocyte-macrophage interaction with erythrocytes. Exp Hematol (1983) 0.81
Reappraisal of the role of anti-i in haemolytic anaemia in infectious mononucleosis. Br J Haematol (1973) 0.81
Congenital dyserythropoietic anemia (CDA) with increased red cell lipids. Am J Med (1974) 0.81
Autoimmune hemolytic anemia associated exclusively with IgA of Rh specificity. Transfusion (1979) 0.81
Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis. Clin Immunol Immunopathol (1980) 0.80
A clinically significant erythrocyte antibody detectable only by 51Cr survival studies. Transfusion (1983) 0.80
Studies on the immune response to penicillin and cephalothin in humans. I. Optimal conditions for titration of hemagglutinating penicillin and cephalothin antibodies. J Immunol (1971) 0.80
Erythrocyte age-fractionation using a Percoll-Renografin density gradient: application to autologous red cell antigen determinations in recently transfused patients. Am J Clin Pathol (1983) 0.79
Paroxysmal cold hemoglobinuria: report of a case with an exceptionally high thermal range Donath-Landsteiner antibody. Blood (1971) 0.79
The relationship between hemolytic and immunodiffusion methods for measurement of C4 in patients with immunologic disorders. Am J Clin Pathol (1975) 0.79